v3.24.3
Stockholders’ Equity (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2024
Dec. 31, 2023
Equity Controlling Interest    
Schedule of Common Stock

 

      
Schedule of Common Stock     
Issuance of Common Stock for compensation and as payment in lieu of cash payments for accrued liabilities   2,564,492 
Exercise of options (Note 10)   48,718 
Issuance of Common Stock converted for Convertible Note   105,440 
      
Total   2,718,650 

 

As of December 31, 2021   

2,512,815

 
Issuance of Common Stock for legal settlement   3,000 
Exercise of options (Note 11)   3,006 
Restricted stock award   8,224 
As of December 31, 2022
   

2,527,045

 
Issuance of common stock   

350,000

 
As of December 31, 2023   

2,877,045

 
Schedule of Common Stock Warrant

 

           Weighted     
       Weighted   Average     
       Average   Remaining   Aggregate 
   Number of   Exercise   Contractual   Intrinsic 
   Shares   Price   Life (years)   Value 
Outstanding at December 31, 2023   24,415    0.11    1.82    1,200,387 
Granted   -    -    -      
Exercised   -    -    -      
Forfeited/cancelled   -    -    -      
Outstanding at June 30, 2024   24,415   $0.11    1.32   $1,200,387 

           Weighted     
       Weighted   Average     
       Average   Remaining   Aggregate 
   Number of   Exercise   Contractual   Intrinsic 
   Shares   Price   Life (years)   Value 
Outstanding at December 31, 2021   19,784   $2.20    4.0   $272,638 
Granted   4,631    151.20    3.8    0 
Exercised   -    -    -      
Forfeited/cancelled   -    -    -      
Outstanding at December 31, 2022   24,415    0.11    2.8    1,200,387 
Granted   -    -    -      
Exercised   -    -    -      
Forfeited/cancelled   -    -    -      
Outstanding at December 31, 2023   24,415   $0.11    1.8   $1,200,387 

 

Beneficial Conversion Feature - Convertible Debt

 

As detailed in Note 10 - Notes Payable and Convertible Debt, the Company has issued two series of convertible debt. Both issuances resulted in the recognition of the beneficial conversion features contained within both of the instruments. The Company recognized the proceeds allocable to the beneficial conversion feature of $8,480,697 as additional paid in capital and a corresponding debt discount of $2,795,000. This additional paid in capital is reflected in the accompanying consolidated Statements of Equity.

 

Earnout Shares

 

As detailed in Note 4 - as part of the TDAC Combination as of December 31, 2021 a total of 5,000,000 Earnout Shares were eligible for issuance until December 31, 2022. Conditions for the earnout were not met and the potential earnout shares were forfeited on December 31, 2022.